This informational video discusses the PrEP pill. It includes verbal narration as well as signed American Sign Language.

This informational video discusses the basics about STDs and how they are transmitted.

This webinar features an exchange between Project Manager, Ciarra "Ci Ci" Covin (The Well Project) and Latesha Elopre, MD, MSPH (University of Alabama at Birmingham) to uplift the unique needs and priorities and insights of Black women living with and vulnerable to HIV, with an emphasis on the US South. It also highlights optimal care for women and provide participants with best practices to improve their capacity to serve the needs of women living with and vulnerable to HIV. This program is supported through a grant from NASTAD.

This webpage is an online group for qualified liver specialists who are knowledgeable about chronic hepatitis B to be listed in the Hepatitis B Foundation's Physician Directory.

RAISE and NASTAD’s webinar, “Program Evaluation Essentials for EHE” took place on Tuesday, January 23, 2024. Dr. Roxanne Kerani discussed key evaluation methods and provided applied examples of public health HIV program evaluations. 

This guideline discusses pharmaceutical company patient assistance programs and cost-sharing assistance programs for HIV treatment.

This guideline discusses pharmaceutical company patience assistance and cost-sharing assistance programs for viral hepatitis.

This guide explains how patient assistance programs (PAPs) are run by, or in association with, pharmaceutical companies to provide free or low-cost medications to people with low incomes who generally do not qualify for any other insurance or assistance programs (such as Medicaid, Medicare, or AIDS Drug Assistance Programs). Some company PAPs may be open to certain insured people with low incomes to help with affordability challenges associated with out-of-pocket medication cost-sharing requirements. 

This waiting room poster emphasizes that HIV testing is for everyone and that getting tested is the only way to confirm HIV status. It is intended to be used in health care settings.